Azithromycin is often sold under the brand-name Z-Pak and treats various kinds of bacterial infections, including respiratory infections.
Teva said its azithromycin products will be on backorder for an unknown amount of time.
Pfizer, which sells azithromycin under the brand-name Zithromax, said it expects new shipments to come in May.
Providers have been using azithromycin in combination with hydroxychloroquine to treat severely ill COVID-19 patients, though it hasn’t been proven to be effective in clinical trials.
The National Institutes of Health recently recommended against using azithromycin in combination with hydroxychloroquine due to potential side effects.
More articles on pharmacy:
CMS cleared to survey 340B hospitals on their drug acquisition costs
SSM Health to close 2 retail pharmacies
The race to develop a COVID-19 vaccine: 5 updates
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
